Genetic and epigenetic instability in human pluripotent stem cells

Human Reproduction Update

Volumn 19, Issue 2, 2013, Pages 187-205

  Nguyen, H T ^a   Geens, M ^a   Spits, C ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Differentiation capacity; Epigenetics; Genome integrity; Human pluripotent stem cells; Malignancy

Indexed keywords

BIOLOGICAL MARKER; CD30 ANTIGEN; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANEUPLOIDY; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; DNA DAMAGE; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; MALIGNANT TRANSFORMATION; MITOCHONDRIAL GENOME; OXYGEN TENSION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; X CHROMOSOME INACTIVATION;

ANEUPLOIDY; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DIPLOIDY; EPIGENESIS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUTATION; PLURIPOTENT STEM CELLS; X CHROMOSOME INACTIVATION;

EID: 84874488315     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dms048     Document Type: Review

References (112)

1. Allegrucci C, Wu YZ, Thurston A, Denning CN, Priddle H, Mummery CL, Ward-van Oostwaard D, Andrews Peter W, Stojkovic M, Smith N et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum Mol Genet 2007;16:1253-1268.
2. Amenduni M, DeFilippis R, Cheung AY, Disciglio V, Epistolato MC, Ariani F, Mari F, Mencarelli MA, Hayek Y, Renieri A et al. iPScells to model CDKL5-related disorders. Eur J Hum Genet 2011;19:1246-1255.
3. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29:1132-1144.
4. Ananiev G, Williams EC, Li H, Chang Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PloS One 2011;6:e25255.
5. Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P, Draper JS. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 2005;33:1526-1530.
6. Baker DEC, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H, Andrews PW. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215.
7. Ben-David U, Benvenisty N, Mayshar Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle 2010;9:4603-4604.
8. Ben-David U, Benvenisty N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells 2012;30:612-622.
9. Ben-Yosef D, Amit A, Malcov M, Frumkin T, Ben-Yehudah A, Eldar I, Mey-Raz N, Azem F, Altarescu G, Renbaum P et al. Female sex bias in human embryonic stem cell lines. Stem Cells Dev 2012;21:363-372.
10. Beroukhim R, Mermel CH, Porter D, Wei G, Donovan J, Barretina J, Boehm JS, Urashima M, Henry KTM, Pinchback RM et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010;463:899-905.
11. Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S, Plaia TW, Auerbach JM, Arking DE et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006;16:1075-1083.
12. Bogomazova AN, Lagarkova M, Tskhovrebova LV, Shutova MV, Kiselev SL. Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2. Aging 2011;3:584-596.
13. Brockdorff N. X-chromosome inactivation: closing in on proteins that bind Xist RNA. Trends Genet 2002;18:352-358.
14. Bruck T, Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res 2011;6:187-193.
15. Buzzard JJ, Gough NM, Crook JM, Colman A. Karyotype of human ES cells during extended culture. Nat Biotechnol 2004;22:381-382.
16. Caisander G, Park H, Frej K, Lindqvist J, Bergh C, Lundin K, Hanson C. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res 2006;14:131-137.
17. Calvanese V, Horrillo A, Hmadcha A, Suarez-Alvarez B, Fernandez AF, Lara E, Casado S, Menendez P, Bueno C, Garcia-Castro J et al. Cancer genes hypermethylated in human embryonic stem cells. PloS One 2008;3:e3294.
18. Catalina P, Montes R, Ligero G, Sanchez L, de la Cueva T, Bueno C, Leone PE, Menendez P. Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?. Mol Cancer 2008;7:76.
19. Chaerkady R, Kerr C, Kumaran K, Marimuthu A, Gearhart J, Pandey A. Comparative proteomics of human embryonic stem cells and embryonal carcinoma cells. Proteomics 2011;10:1359-1373.
20. Chan EM, Yates F, Boyer LF, Schlaeger TM, Daley GQ. Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17. Cloning Stem Cells 2008;10:107-118.
21. Chen HF, Kuo HC, Chen W, Wu FC, Yang YS, Ho HN. A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Hum Reprod 2009; 24:71-80.
22. Cheung AYL, Horvath LM, Carrel L, Ellis J. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry 2012;3:24.
23. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
24. Chung TL, Turner JP, Thaker NY, Kolle G, Cooper-White JJ, Grimmond SM, Pera MF, Wolvetang EJ. Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells. Stem cells 2010;28:1782-1793.
25. Cowan CA, Klimanskaya I, Mcmahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, Mcmahon AP, Powers D et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004;350:1353-1356.
26. Darnfors C, Flodin A, Andersson K, Caisander G, Lindqvist J, Hyllner J, Wahlström J, Sartipy P. High-resolution analysis of the subtelomeric regions of human embryonic stem cells. Stem Cells 2005;23:483-488.
27. Dhara SK, Benvenisty N. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res 2004;32:3995-4002.
28. Diaz Perez SV, Kim R, Li Z, Marquez VE, Patel S, Plath K, Clark AT. Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. Hum Mol Genet 2012;21:751-764.
29. Doi A, Park I, Wen B, Murakami P, Aryee M. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
30. Dormeyer W, Hoof DV, Braam SR, Heck AJR, Mummery CL, Krijgsveld J. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 2008;7:2936-2951.
31. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson J, Andrews PW. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004;22:53-54.
32. Dvash T, Lavon N, Fan G. Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells. PloS One 2010;5:e11330.
33. Elliott AM, Elliott KH, Kammesheidt A. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol 2010; 46:234-242.
34. Enver T, Soneji S, Joshi C, Brown J, Iborra F, Orntoft T, Thykjaer T, Maltby E, Smith K, Abu Dawud R et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005; 14:3129-3140.
35. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. PNAS 2005;102:4783-4788.
36. Fazeli A, Liew CG, Matin MM, Elliott S, Jeanmeure LFC, Wright PC, Moore H, Andrews PW. Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells. Int J Dev Biol 2011;55:175-180.
37. Forsyth NR, Musio A, Vezzoni P, Simpson HRW, Noble BS, McWhir J. Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 2006;8:16-23.
38. Gauthaman K, Manasi N, Bongso A. Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol 2009;157:962-973.
39. Gertow K, Cedervall J, Unger C, Szöke K, Blennow E, Imreh MP, Ahrlund-Richter L. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J Cell Biochem 2007; 100:1518-1525.
40. Gerwe BA, Angel PM, West FD, Hasneen K, Young A, Orlando R, Stice SL. Membrane proteomic signatures of karyotypically normal and abnormal human embryonic stem cell lines and derivatives. Proteomics 2011;11:2515-2527.
41. Gopalakrishna-Pillai S, Iverson LE. Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitors. BMC Med Genomics 2010;3:12.
42. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-67.
43. Hall LL, Byron M, Butler J, Becker K, Nelson A, Amit M, Itskovitz-Eldor J, Stein J, Stein G, Ware C et al. X-Inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol 2008; 216:445-452.
44. Harrison NJ, Barnes J, Jones M, Baker D, Gokhale PJ, Andrews PW. CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes. Stem Cells 2009;27:1057-1065.
45. Hastings PJ, Lupski JR, Rosenberg SM, Ira G. Mechanisms of change in gene copy number. Nature Rev Genet 2009;10:551-564.
46. Herszfeld D, Wolvetang E, Langton-Bunker E, Chung TL, Filipczyk AA, Houssami S, Jamshidi P, Koh K, Laslett AL, Michalska A et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 2006; 24:351-357.
47. Hoffman LM, Hall L, Batten JL, Young H, Pardasani D, Baetge EE, Lawrence J, Carpenter MK. X-inactivation status varies in human embryonic stem cell lines. Stem Cells 2005;23:1468-1478.
48. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Närvä E, Ng S, Sourour M, Hämäläinen R, Olsson C et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:58-62.
49. Imreh MP, Gertow K, Cedervall J, Unger C, Holmberg K, Szöke K, Csöregh L, Fried G, Dilber S, Blennow E et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem 2006;99:508-516.
50. Inzunza J, Sahlén S, Holmberg K, Strömberg AM, Teerijoki H, Blennow E, Hovatta O, Malmgren H. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol Hum Reprod 2004;10:461-466.
51. Josephson R. Molecular cytogenetics; making it safe for human embryonic stem cells to enter the clinic. Expert Rev Mol Diagn 2007;7:395-406.
52. Kidd JM, Graves T, Newman TL, Fulton R, Hayden HS, Malig M, Kallicki J, Kaul R, Wilson RK, Eichler EE. A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 2010;143:837-847.
53. Kim KP, Thurston A, Mummery C, Ward-van Oostwaard D, Priddle H, Allegrucci C, Denning C, Young LE. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res 2007;17:1731-1742.
54. Kim D, Kim C, Moon J, Chung Y, Chang M, Han B, Ko S, Yang E, Cha K, Lanza R et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-476.
55. Lagarkova MA, Volchkov PY, Philonenko ES, Pfannkuche K, Prokhorovich MA, Zabotina T, Hescheler J, Kiselev SL. CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs. Cell cycle 2008;7:3610-3612.
56. Lefort N, Feyeux M, Bas C, Féraud O, Bennaceur-Griscelli A, Tachdjian G, Peschanski M, Perrier AL. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 2008;26:1364-1366.
57. Lengner CJ, Gimelbrant AA, Erwin JA, Cheng AW, Guenther MG, Welstead GG, Alagappan R, Frampton GM, Xu P, Muffat J et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 2010;141:872-883.
58. Liao H, Zhang S, Cheng D, Ouyang Q, Lin G, Gu Y, Lu C, Gong F, Lu G. Cytogenetic analysis of human embryos and embryonic stem cells derived from monopronuclear zygotes. J Assist Reprod Genet 2009;26:583-589.
59. Lim H, Han J, Woo D, Kim SE, Kim SK. Biochemical and morphological effects of hypoxic environment on human embryonic stem cells in long-term culture and differentiating embryoid bodies. Mol Cells 2011;31:123-132.
60. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009;462:315-322.
61. Lister R, Pelizzola M, Kida Y, Hawkins R, Nery J, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471:68-73.
62. Liu X, Wu H, Loring J, Hormuzdi S, Disteche CM, Bornstein P, Jaenisch R. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn 1997;209:85-91.
63. Liu W, Sun X. Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells. Hum Reprod 2009;24:1834-1843.
64. Liu W, Yin Y, Jiang Y, Kou C, Luo Y, Huang S, Zheng Y, Li S, Li Q, Guo L et al. Genetic and epigenetic X-chromosome variations in a parthenogenetic human embryonic stem cell line. J Assist Reprod Genet 2011;28:303-313.
65. Longo L, Bygrave A, Grosveld FG, Pandolfi PP. The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res 1997;6:321-328.
66. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008;105:2883-2888.
67. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005;37:1099-1103.
68. Marchetto MCN, Carromeu C, Acab A, Yu D, Yeo G, Mu Y, Chen G, Gage FH, Muotri AR. A model for neural development and treatment of Rett Syndrome using human induced pluripotent stem cells. Cell 2010;143:527-539.
69. Martins-Taylor K, Nisler SB, Taapken SM, Compton T, Crandall L, Montgomery KD, Lalande M, Xu RH. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011;29:6-9.
70. Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod 2009; 24:2477-2489.
71. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7:521-531.
72. Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 2012;10:595-609.
73. Mitalipova MM, Rao RR, Hoyer DM, Johnson J, Meisner LF, Jones KL, Dalton S, Stice SL. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 2005;23:19-20.
74. Momcilovic O, Knobloch L, Fornsaglio J, Varum S, Easley C, Schatten G. DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One 2010;5:e13410.
75. Moreira de Mello JC, de Araújo ESS, Stabellini R, Fraga AM, de Souza JES, Sumita DR, Camargo A, Pereira LV. Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PloS One 2010;5:e10947.
76. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010;28:371-377.
77. Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Müller FJ, Wang YC, Boscolo FS et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 2012; 10:620-634.
78. Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genetics 2011;7:e1002085.
79. O'Leary T, Heindryckx B, Lierman S, van Bruggen D, Goeman JJ, Vandewoestyne M, Deforce D, de Sousa Lopes SM, De Sutter P. Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol 2012;30:278-282.
80. Peterson SE, Westra JW, Rehen SK, Young H, Bushman DM, Paczkowski CM, Yung YC, Lynch CL, Tran HT, Nickey KS et al. Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One 2011; 6:e23018.
81. Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-2690.
82. Pomp O, Dreesen O, Leong DF, Meller-Pomp O, Tan TT, Zhou F, Colman A. Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 2011;9:156-165.
83. Prigione A, Lichtner B, Kuhl H, Struys E, Wamelink M, Lehrach H, Ralser M, Timmermann B, Adjaye J. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells 2011;29:1338-1348.
84. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. PNAS 2000;97:5237-5242.
85. Romero-Lanman EE, Pavlovic S, Amlani B, Chin Y, Benezra R. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem Cells Dev 2012;21:384-393.
86. Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, Carpenter MK. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 2004;229:259-274.
87. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen R. Epigenetic status of human embryonic stem cells. Nature Genet 2005;37:585-587.
88. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen R. Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet 2007;16:R243-R251.
89. Scotto L, Narayan G, Nandula SV, Arias-pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer; potential role in progression. Genes Chromosomes Cancer 2008;47:755-765.
90. Seol HW, Oh SK, Park YB, Kim HS, Baek JA, Seo J, Kim EH, Ku SY, Kim SH, Choi YM et al. Separation and maintenance of normal cells from human embryonic stem cells with trisomy 12 mosaicism. Chromosome Res 2008;16:1075-1084.
91. Shen Y, Chow J, Wang Z, Fan G. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 2006; 15:2623-2635.
92. Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. PNAS 2008;105:4709-4714.
93. Silva SS, Rowntree RK, Mekhoubad S, Lee JT. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. PNAS 2008;105:4820-4825.
94. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y, Van der Elst J, Liebaers I, Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 2008;26:1361-1363.
95. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-181.
96. Sugawara A, Goto K, Sotomaru Y, Sofuni T, Ito T. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med 2006; 56:31-34.
97. Suhr ST, Chang EA, Tjong J, Alcasid N, Perkins G, Goissis MD, Ellisman MH, Perez GI, Cibelli JB. Mitochondrial rejuvenation after induced pluripotency. PloS One 2010;5:e14095.
98. Sun X, Long X, Yin Y, Jiang Y, Chen X, Liu W, Zhang W, Du H, Li S, Zheng Y et al. Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes. Hum Reprod 2008;23:2185-2193.
99. Taapken SM, Nisler BS, Newton M, Sampsell-Barron TL, Leonhard K, McIntire EM, Montgomery KD. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 2011;29:313-314.
100. Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke XS, Oyan AM, Kalland K-H, Rotter V et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PloS One 2011;6:e14632.
101. Tanasijevic B, Dai B, Ezashi T, Livingston K, Roberts RM, Rasmussen TP. Progressive accumulation of epigenetic heterogeneity during human ES cell culture. Epigenetics 2009;4:330-338.
102. Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sean P, Aimiuwu O, Lindgren A, Hakimian S, Zack JA et al. Female human iPS cells retain an inactive X-chromosome. Cell Stem Cell 2010;7:329-342.
103. Thomson A, Wojtacha D, Hewitt Z, Priddle H, Sottile V, Di Domenico A, Fletcher J, Waterfall M, Corrales NL, Ansell R et al. Human embryonic stem cells passaged using enzymatic methods retain a normal karyotype and express CD30. Cloning Stem Cells 2008;10:89-106.
104. Tichy ED. Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells. Exp Biol Med 2011;236:987-996.
105. van den Berg IM, Laven JSE, Stevens M, Jonkers I, Galjaard RJ, Gribnau J, van Doorninck JH. X chromosome inactivation is initiated in human preimplantation embryos. Am J Hum Genet 2009;84:771-779.
106. van den Berg IM, Galjaard RJ, Laven JSE, van Doorninck JH. XCI in preimplantation mouse and human embryos; first there is remodelling. Hum Genet 2011; 130:203-215.
107. Werbowetski-Ogilvie TE, Bossé M, Stewart M, Schnerch A, Ramos-Mejia V, Rouleau A, Wynder T, Smith MJ, Dingwall S, Carter T et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 2009;27:91-97.
108. Werbowetski-Ogilvie TE, Schnerch A, Rampalli S, Mills CE, Lee JB, Hong SH, Levadoux-Martin M, Bhatia M. Evidence for the transmission of neoplastic properties from transformed to normal human stem cells. Oncogene 2011; 30:4632-4644.
109. Westfall SD, Sachdev S, Das P, Hearne LB, Hannink M, Roberts RM, Ezashi T. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev 2008;17:869-881.
110. Wu H, Kim KJ, Mehta K, Paxia S, Sundstrom A, Anantharaman T, Kuraishy AI, Doan T, Ghosh J, Pyle AD et al. Copy number variant analysis of human embryonic stem cells. Stem Cells 2008;26:1484-1489.
111. Yang S, Lin G, Tan YQ, Zhou D, Deng LY, Cheng DH, Luo SW, Liu TC, Zhou XY, Sun Z et al. Tumor Progression of Culture-Adapted Human Embryonic Stem Cells During Long-Term Culture. Genes Chromosomes Cancer 2008; 47:665-679.
112. Yang S, Lin G, Tan YQ, Deng LY, Yuan D, Lu GX. Differences between karyotypically normal and abnormal human embryonic stem cells. Cell Prolif 2010;43:195-206.